Literature DB >> 32382820

Gadoxetic acid-enhanced MRI for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: can hypointensity on the late portal venous phase be used as an alternative to washout?

Kyoung A Baek1, Seung Soo Kim2, Hyeong Cheol Shin1, Jeong Ah Hwang1,3, Seo-Youn Choi4, Woong Hee Lee1, Chan Ho Park1, Hyoung Nam Lee1, Nam Hun Heo5.   

Abstract

PURPOSE: To investigate the added value of considering hypointensity on late portal venous phase (LPVP) images as washout for diagnosis of hepatocellular carcinoma (HCC) using gadoxetic acid-enhanced MRI (Gd-EOB-MRI) in patients with chronic liver disease (CLD).
METHODS: This retrospective study comprised 97 patients at high risk for HCC who underwent Gd-EOB-MRI including unenhanced, multi-arterial phase, conventional portal venous phase (CPVP, 60 s), and LPVP (mean, 99.9 ± 9.1 s; range, 90-119 s) images. A total of 115 hepatic lesions were identified by histopathological or clinical diagnosis. Three independent radiologists assessed the MRI images by consensus. Diagnosis of HCC was made using criteria of arterial hyperenhancement and hypointensity relative to the surrounding liver parenchyma (1) on CPVP or (2) on CPVP and/or LPVP images. The generalized estimating equation was used to compare diagnostic performance for HCC between Criterion 1 and 2.
RESULTS: In 82 HCCs, the frequency of hypointensity differed significantly between the CPVP and LPVP images (64.6% [53/82] vs. 84.1% [69/82], P < 0.001). Among 33 non-HCCs, two cHCC-CCs showed additional hypointensity on LPVP than CPVP images (33.3% [11/33] vs. 39.4% [13/33], P = 0.500). Criterion 2 provided significantly greater sensitivity for diagnosing HCC than Criterion 1 (54.9% [45/82] vs. 74.4% [61/82], P < 0.001), with relatively little reduction in specificity (90.9% [30/33] vs. 84.8% [28/33], P = 0.145).
CONCLUSION: Additional use of LPVP hypointensity as washout could significantly improve sensitivity for HCC diagnosis when utilizing Gd-EOB-MRI in patients with CLD, without a significant decrease in specificity.

Entities:  

Keywords:  Gadoxetic acid; Hepatocellular carcinoma; Liver neoplasms; Magnetic resonance imaging

Year:  2020        PMID: 32382820     DOI: 10.1007/s00261-020-02553-z

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  41 in total

1.  Accuracy and disagreement of computed tomography and magnetic resonance imaging for the diagnosis of small hepatocellular carcinoma and dysplastic nodules: role of biopsy.

Authors:  Thomas Sersté; Vincent Barrau; Violaine Ozenne; Marie-Pierre Vullierme; Pierre Bedossa; Olivier Farges; Dominique-Charles Valla; Valérie Vilgrain; Valérie Paradis; Françoise Degos
Journal:  Hepatology       Date:  2012-01-30       Impact factor: 17.425

2.  Multidetector-row computed tomography (MDCT) for the diagnosis of hepatocellular carcinoma in cirrhotic candidates for liver transplantation: prevalence of radiological vascular patterns and histological correlation with liver explants.

Authors:  Angelo Luca; Settimo Caruso; Mariapina Milazzo; Giuseppe Mamone; Gianluca Marrone; Roberto Miraglia; Luigi Maruzzelli; Vincenzo Carollo; Marta Ida Minervini; Giovanni Vizzini; Salvatore Gruttadauria; Salvatore Grutttadauria; Bruno Gridelli
Journal:  Eur Radiol       Date:  2009-10-03       Impact factor: 5.315

3.  Diagnostic efficacy of gadoxetic acid-enhanced MRI in the detection of hepatocellular carcinomas: comparison with gadopentetate dimeglumine.

Authors:  G Park; Y K Kim; C S Kim; H C Yu; S B Hwang
Journal:  Br J Radiol       Date:  2010-08-03       Impact factor: 3.039

4.  The diagnostic and economic impact of contrast imaging techniques in the diagnosis of small hepatocellular carcinoma in cirrhosis.

Authors:  Angelo Sangiovanni; Matteo A Manini; Massimo Iavarone; Raffaella Romeo; Laura V Forzenigo; Mirella Fraquelli; Sara Massironi; Cristina Della Corte; Guido Ronchi; Maria Grazia Rumi; Piero Biondetti; Massimo Colombo
Journal:  Gut       Date:  2009-12-01       Impact factor: 23.059

Review 5.  Evidence Supporting LI-RADS Major Features for CT- and MR Imaging-based Diagnosis of Hepatocellular Carcinoma: A Systematic Review.

Authors:  An Tang; Mustafa R Bashir; Michael T Corwin; Irene Cruite; Christoph F Dietrich; Richard K G Do; Eric C Ehman; Kathryn J Fowler; Hero K Hussain; Reena C Jha; Adib R Karam; Adrija Mamidipalli; Robert M Marks; Donald G Mitchell; Tara A Morgan; Michael A Ohliger; Amol Shah; Kim-Nhien Vu; Claude B Sirlin
Journal:  Radiology       Date:  2017-11-21       Impact factor: 11.105

6.  Gadoxetic acid-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma.

Authors:  Seong Hyun Kim; Seung Hoon Kim; Jongmee Lee; Min Ju Kim; Yong Hwan Jeon; Yulri Park; Dongil Choi; Won Jae Lee; Hyo K Lim
Journal:  AJR Am J Roentgenol       Date:  2009-06       Impact factor: 3.959

Review 7.  Epidemiology of hepatocellular carcinoma: consider the population.

Authors:  Sahil Mittal; Hashem B El-Serag
Journal:  J Clin Gastroenterol       Date:  2013-07       Impact factor: 3.062

8.  Management of hepatocellular carcinoma: an update.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425

Review 9.  Emerging Role of Hepatobiliary Magnetic Resonance Contrast Media and Contrast-Enhanced Ultrasound for Noninvasive Diagnosis of Hepatocellular Carcinoma: Emphasis on Recent Updates in Major Guidelines.

Authors:  Tae Hyung Kim; Jeong Hee Yoon; Jeong Min Lee
Journal:  Korean J Radiol       Date:  2019-06       Impact factor: 3.500

10.  A leap for the journal: Clinical and Molecular Hepatology enters a new era.

Authors:  Yoon Jun Kim
Journal:  Clin Mol Hepatol       Date:  2019-12-17
View more
  2 in total

1.  Gadoxetic Acid-Based MRI for Decision-Making in Hepatocellular Carcinoma Employing Perfusion Criteria Only-A Post Hoc Analysis from the SORAMIC Trial Diagnostic Cohort.

Authors:  Max Seidensticker; Ingo G Steffen; Irene Bargellini; Thomas Berg; Alberto Benito; Bernhard Gebauer; Roberto Iezzi; Christian Loewe; Musturay Karçaaltincaba; Maciej Pech; Christian Sengel; Otto van Delden; Vincent Vandecaveye; Christoph J Zech; Jens Ricke
Journal:  Curr Oncol       Date:  2022-01-27       Impact factor: 3.677

Review 2.  Imaging diagnosis of hepatocellular carcinoma: Future directions with special emphasis on hepatobiliary magnetic resonance imaging and contrast-enhanced ultrasound.

Authors:  Junghoan Park; Jeong Min Lee; Tae-Hyung Kim; Jeong Hee Yoon
Journal:  Clin Mol Hepatol       Date:  2021-12-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.